logo

Biotech Stocks Facing FDA Decision In January 2020

Drugs Awaiting FDA Approval
Drugs Awaiting FDA Approval

As we begin the first month of the year 2020, it’s time to take a look at the drug candidates lined up at the FDA altar awaiting the federal agency's decision.

Forty-eight *novel drugs and biologics received FDA approval in 2019 compared to an all-time high of 59 in 2018. The only other time when the approval tally was above 50 was in 1996 – with 53 approvals.

*Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before.

Share



>